The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy

NCT03659513 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2023-07-27

No results posted yet for this study

Summary

This study will examine the pharmacokinetics of the various, routinely given antibiotics, sedatives, and opioids in patients undergoing venous-venous extra-corporal oxygenation (ECMO). Little is known about the distribution and effectiveness of antibiotics in this particular patient population.

Conditions

  • Hypoxia
  • Extracorporeal Membrane Oxygenation Complication

Sponsors & Collaborators

Principal Investigators

  • Jacob Gutsche, MD · University of Pennsylvania

  • Krzysztof Laudanski, MD, PhD · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-13
Primary Completion
2022-10-24
Completion
2022-10-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03659513 on ClinicalTrials.gov